The Cigna Group (BVMF:C1IC34)
Brazil · Delayed Price · Currency is BRL 383.16
0.00 (0.00%)
At close: Dec 22, 2025
The Cigna Group Revenue
The Cigna Group had revenue of $67.18B USD in the quarter ending June 30, 2025, with 11.00% growth. This brings the company's revenue in the last twelve months to $262.02B, up 20.23% year-over-year. In the year 2024, The Cigna Group had annual revenue of $247.12B with 26.56% growth.
Revenue (ttm)
$262.02B
Revenue Growth
+20.23%
P/S Ratio
0.28
Revenue / Employee
$3.56M
Employees
73,500
Market Cap
405.33B BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 247.12B | 51.86B | 26.56% |
| Dec 31, 2023 | 195.27B | 14.75B | 8.17% |
| Dec 31, 2022 | 180.52B | 6.45B | 3.70% |
| Dec 31, 2021 | 174.07B | 13.67B | 8.52% |
| Dec 31, 2020 | 160.40B | 6.84B | 4.45% |
| Dec 31, 2019 | 153.57B | 104.92B | 215.65% |
| Dec 31, 2018 | 48.65B | 6.84B | 16.37% |
| Dec 31, 2017 | 41.81B | 1.97B | 4.94% |
| Dec 31, 2016 | 39.84B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Empreendimentos Pague Menos | 14.27B |
| Diagnósticos da América | 12.57B |
| Fleury | 8.07B |
| Hypera | 6.97B |
| Oncoclínicas do Brasil Serviços Médicos | 5.94B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |